Convalescent Plasma Transfusion Appears Safe for Patients With COVID-19
The transfusion of human convalescent plasma as a mitigation and treatment option for patients with COVID-19 is associated with a low rate of serious adverse events.
News
LATEST NEWS
Smokers With Sleep Disturbances Are Less Likely to Quit Smoking
Individuals who smoke and experience sleep disturbances are less likely to quit smoking.
Intravenous Vitamin C Linked to Early Recovery in Critically Ill COVID-19 Patient
The patient, a 74-year-old female, presented to the ER after experiencing a low grade fever, cough, and shortness of breath for 2 days.
DNA-Based Therapy Receives Orphan Drug Status for Recurrent Respiratory Papillomatosis
The FDA has granted Orphan Drug designation to INO-3107, a DNA plasmid immunotherapy, for the treatment of recurrent respiratory papillomatosis, a rare disease caused by human papillomavirus types 6 and 11 infections.
Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Bacterial, Fungal Coinfection Uncommon in COVID-19
Although bacterial and fungal infections appear to be uncommon in patients hospitalized with COVID-19, many patients received antibiotics during their hospitalization.
Early Predictors of Survival in Acute Respiratory Distress Syndrome
Changes in Radiographic Assessment of Lung Edema (RALE) scores in patients with ARDS were independently associated with survival.
Prone Position Coronary Angiography in ARDS-Related COVID-19 Feasible
A coronary angiography was performed in the prone position in a patient with ARDS related to COVID-19, in an effort to maintain reasonable oxygen saturation.
UPCOMING MEETINGS
FEBRUARY 22-25
American Academy of Allergy, Asthma and Immunology (AAAAI) 2019 Annual Meeting
San Francisco, CA
February 27-28
5th International Conference on Respiratory and Pulmonary Medicine
Paris, France
April 10-13
ELCC 2019: European Lung Cancer Conference
Geneva, Switzerland
DRUG NEWS FROM MPR
Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD
Immune Responses Observed in All Participants Dosed With COVID-19 Vaccine Candidate
Combined Long-Acting Bronchodilator Therapy Compared With Monotherapy for COPD
Brigatinib Approved as First-Line Treatment for ALK-Positive Metastatic NSCLC
Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19
FDA: Scammers Continue to Sell Unproven Products for COVID-19
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
FDA Approves Imfinzi for Extensive-Stage Small Cell Lung Cancer
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
Pirfenidone Gets Breakthrough Therapy Status for Unclassifiable Interstitial Lung Disease
FDA: Cases of Respiratory Depression With Gabapentinoids Reported
New Cheek Swab Helps Rule Out Genetic Form of COPD
FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation
Mepolizumab Approved for Younger Patients With Severe Eosinophilic Asthma
Fixed-Dose, Triple-Combination Therapy Effective in COPD Trial
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
